Toward freedom from cancer pain in Japan

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 21, Issue 3, 2007, Pages 37-42

  Otsuka, Kuniko ^a,b   Yasuhara, Hajime ^a  

^a SHOWA UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Education; End of life care; Health insurance; Japan; Opioids; Pain relief; Patient rights

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; MORPHINE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE;

ARTICLE; BREAST CANCER; CANCER; CANCER INCIDENCE; CANCER PAIN; CAUSE OF DEATH; DOCTOR PATIENT RELATION; DRUG FORMULATION; DRUG UTILIZATION; ETHICS; HUMAN; JAPAN; LIVER CANCER; LUNG CANCER; MORTALITY; PALLIATIVE THERAPY; PATIENT CARE; QUALITY OF LIFE; STOMACH CANCER;

ANALGESICS, OPIOID; DRUG UTILIZATION; FENTANYL; HUMANS; JAPAN; MORPHINE; NEOPLASMS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 34548672577     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1300/J354v21n03_06     Document Type: Article

References (25)

1. The World Health Report 2000, Health Systems: Improving Performance, pages 149-196, Geneva, World Health Organization, 2000.
2. Annual Report of the Japanese Government on Health, Heisei 18th Welfare White Paper, pages 369-71.
3. Annual Report of the Japanese Government on Health, Heisei 18th Welfare White Paper, page 391.
4. Annual Report of the Japanese Government on Health, Heisei 18th Welfare White Paper, page 372.
5. Cancer Statistics in Japan 2003. URL:http://www.ncc.go.jp/en/statistics/ 2003/index.html. accessed February 2007.
6. Japanese Ministry of Health Labour and Warfare. Demand for opioids and psychotropic drugs, General condition of opioids and stimulant administration, Tokyo, Japan; 2006:8-17.
7. Interview form of Durotep Patch, Janssen Pharmaceutical K.K. 2002 March.
8. World Health Organization. Cancer Pain Relief. Geneva, World Health Organization 1986.
9. Interview form of MS Contin, Shionogi and Co., Ltd, 1989 January.
10. Japanese Pharmacopeia version XII revised, Ministry of Health, Labour, and Warfare, Tokyo, Japan, 1991.
11. Ministry of Health, Labor, and Warfare Demand for opioids and psychotropic drug, General condition of opioids and the stimulant administration, Tokyo, Japan, 2006:18-22.
12. The 86th Japanese National Examination for Nurses, Ministry of Health, Labour, and Warfare, Tokyo, Japan, 1997.
13. The 83rd Japanese National Examination for Pharmacists, Ministry of Health, Labour, and Warfare, Tokyo, Japan, 1998.
14. Yamanouchi T, Nagata Y, Noriyuki K. Consumption of Morphine Preparations in Toyama Medical and Pharmaceutical University Hospital, Yakugaku Zasshi. 12(1):13-18, 2004.
15. Annual Report of the International Narcotics Control Board, Geneva, World Health Organization, February 23, 2003.
16. Annual Report of the International Narcotics Control Board, Geneva, World Health Organization, March 3, 2004.
17. Takeda F, Uki J. The manual on how to use morphine for cancer patients appears Ministry of Health Labor and Warfare, Japan, 1993.
18. Takeda F. The development of use of oral morphine within the last 10 years in Japan. Eur J Pain 2001;5:79-82.
19. Uki J, Mendoza T, Cleeland SC, Nakamura Y, Takeda F. A brief cancer pain assessment tool in Japanese, The utility of the Japanese Brief Pain Inventory-BPI. J. Pain Symptom Manage. 1998;16:364-73.
20. Hiraga Ichiyou. The recent status of the management of cancer pain. Pain Clinic. 1999;20:479-84.
21. Physician 2004, No 24, pp. 1-18, Life Science Publication, 2004.
22. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Adequacy of cancer pain management in a Japanese Hospital. Jpn J Clin Oncol. 2004;34:37-42.
23. The 22th Annual Meeting of Japanese Society of Social Pharmacy, 2003, Kobe.
24. Japanese Society for Palliative Medicine, http://www.jspm.ne.jp/ Palliative care.
25. Guideline for pain treatment, Japanese Society for Palliative Medicine, accessible at: http://www.jspm.ne.jp/guidelines/index.html